Riverbridge Partners LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 137,179 shares of the healthcare conglomerate's stock after selling 4,840 shares during the period. Riverbridge Partners LLC's holdings in UnitedHealth Group were worth $42,796,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently bought and sold shares of UNH. GAMMA Investing LLC boosted its stake in UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Nuveen LLC acquired a new position in UnitedHealth Group in the first quarter valued at $3,846,764,000. Vanguard Group Inc. raised its holdings in shares of UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP raised its holdings in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. Finally, National Bank of Canada FI raised its holdings in shares of UnitedHealth Group by 137.8% in the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock valued at $859,518,000 after buying an additional 950,928 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
Wall Street Analysts Forecast Growth
UNH has been the subject of a number of research reports. Sanford C. Bernstein upped their target price on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a report on Friday, September 5th. Piper Sandler reduced their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Bank of America increased their price target on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Truist Financial increased their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a report on Tuesday, September 9th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $358.95.
Get Our Latest Report on UnitedHealth Group
UnitedHealth Group Trading Up 1.2%
Shares of UNH opened at $351.87 on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm's 50-day moving average is $298.81 and its two-hundred day moving average is $362.32. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm has a market capitalization of $318.68 billion, a P/E ratio of 15.25, a PEG ratio of 2.27 and a beta of 0.45.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the company posted $6.80 earnings per share. The company's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio is currently 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.